"How can we support our Ukrainian partners in times of war?"—This was the question posed by DZIF scientist Professor Christoph Lange and his colleagues from the Research Center Borstel, Leibniz Lung
The International Day of Women and Girls in Science is celebrated every year on 11 February. Women are still underrepresented worldwide and particularly in the German science system: at 29.4 per cent
The INCubator for Antibacterial Therapies in Europe, INCATE, aims to support innovators in the early stages of developing therapies in the field of antimicrobial resistance. The German Center for
Epstein-Barr Virus (EBV) is widespread and very contagious: according to the World Health Association, more than 90 percent of the global population are infected with this virus throughout their lives
The World Neglected Tropical Diseases Day on 30 January under the motto UNITE.ACT.ELIMINATE draws attention to neglected tropical diseases (NTDs) and the suffering they cause. More than one billion
AiCuris Anti-infective Cures AG and the German Center for Infection Research (DZIF) have announced the signing of a collaboration and license option agreement today. As part of the collaboration, DZIF
BioVersys AG, a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections caused by multi-drug
Study shows efficacy and safety of oral antibiotic therapy in the form of pills for Staphylococcus aureus bloodstream infections. Currently, infusions are the standard treatment / published in ‘The
INCATE (the INCubator for Antibacterial Therapies in Europe) and Kineticos AMR Accelerator Fund I (KAMRA I), have announced the beginning of a new collaboration that aims to enhance the support for
Tuberculosis is currently the infectious disease that causes the most deaths worldwide. Of particular concern is the increasing emergence of multidrug-resistant tuberculosis bacteria, particularly in
